No matter what your age or risk tolerance, investing is a lot easier and likely more successful if your perspective is informed by market history.
Dave S. Gilreath, CFP
Advertisement
Articles by Dave S. Gilreath, CFP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
3
FDA approves first-line Zenflow system for the treatment of BPH
4
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
5
